The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1222 - 1222
Published: Jan. 30, 2025
Alzheimer’s
disease
(AD)
is
one
of
the
most
common
and
severe
forms
dementia
neurodegenerative
disease.
As
life
expectancy
increases
in
line
with
developments
medicine,
elderly
population
projected
to
increase
next
few
decades;
therefore,
an
prevalence
some
diseases,
such
as
AD,
also
expected.
a
result,
until
radical
treatment
becomes
available,
AD
expected
be
more
frequently
recorded
top
causes
death
worldwide.
Given
current
lack
cure
for
only
treatments
available
being
ones
that
alleviate
major
symptoms,
identification
contributing
factors
influence
incidence
crucial.
In
this
context,
genetic
and/or
epigenetic
factors,
mainly
environmental,
disease-related,
dietary,
or
combinations/interactions
these
are
assessed.
review,
we
conducted
literature
search
focusing
on
environmental
air
pollution,
toxic
elements,
pesticides,
infectious
agents,
well
dietary
including
various
diets,
vitamin
D
deficiency,
social
(e.g.,
tobacco
alcohol
use),
variables
affected
by
both
behavior
gut
microbiota.
We
evaluated
studies
beneficial
effects
antibiotics
Mediterranean-DASH
Intervention
Neurodegenerative
Delay
(MIND)
Mediterranean
diets.
Language: Английский
The role of the gut microbiome in Alzheimer's disease pathophysiology
Current Opinion in Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Purpose
of
review
The
present
aims
to
provide
an
overview
the
existing
understanding
role
gut
microbiome
in
Alzheimer's
disease
pathophysiology.
Recent
findings
research
has
highlighted
significant
pathogenesis
via
gut-brain
axis.
However,
precise
mechanisms
by
which
and
its
microbial
metabolites
influence
brain
function
are
not
clearly
understood.
Various
factors,
such
as
diet,
drugs,
lifestyle,
stress,
infections
can
provoke
imbalance
homeostasis,
known
dysbiosis.
This
dysbiosis
impacts
intestinal
blood-brain
barrier
permeability,
elevating
pro-inflammatory
cytokines
contributing
neurodegeneration.
Moreover,
generates
neurotransmitters,
amyloids,
neurotoxins,
metabolites,
may
play
a
systemic
inflammation
disruption
physiological
barriers.
Summary
In
past
decade,
advancements
analysis
technologies
bioinformatics
have
significantly
enhanced
our
disease.
plays
pivotal
regulatory
progression
disease,
closely
interacts
with
pathogenesis,
encompassing
inflammation,
amyloidosis,
neurodegeneration,
tauopathy,
co-pathologies.
Language: Английский
Curli protein: A potential contributor to α-synucleopathy in Parkinson's disease
Nabanita Ghosh,
No information about this author
Krishnendu Sinha
No information about this author
Translational Medicine of Aging,
Journal Year:
2025,
Volume and Issue:
9, P. 41 - 48
Published: Jan. 1, 2025
Language: Английский
Association between cognitive functioning and microbiota-gut-brain axis mediators in a memory clinic population
Frontiers in Cellular Neuroscience,
Journal Year:
2025,
Volume and Issue:
19
Published: March 12, 2025
Introduction
A
growing
body
of
evidence
recognises
the
role
signaling
molecule
microbiota-gut-brain
axis
(MGBA)
in
cognitive
impairment
(CI),
but
data
on
link
with
alterations
specific
domains
are
limited.
We
compared
functioning
several
(i.e.,
memory,
visuo-constructional,
executive,
and
language)
among
cognitively
unimpaired
(CU)
subjects,
patients
CI
due
to
Alzheimer’s
disease
(CI-AD)
not
AD
(CI-NAD).
Then,
we
investigated
association
these
gut
microbiota
(GM),
MGBA
mediators,
neurodegeneration-related
markers.
Materials
methods
The
study
included
34
CI-AD,
38
CI-NAD,
13
CU.
Memory,
language
were
assessed
using
composite
measures.
Faecal
GM
composition
was
inferred
16S
rRNA
gene
sequencing.
mediators
blood
quantification
bacterial
products
(lipolysaccharide,
LPS),
cell
adhesion
molecules
indicative
endothelial
damage,
vascular
changes
or
overexpressed
response
infections,
pro-
anti-inflammatory
cytokines.
Neurodegeneration-related
markers
plasma
phosphorylated
tau
(p-tau181),
neurofilament
light
chain
(NfL),
glial
fibrillary
protein
(GFAP).
Results
CI-NAD
CI-AD
groups
had
significantly
lower
scores
than
CU
group
for
all
(
p
<
0.043).
Associations
modulators
pro-inflammatory
cytokines,
dysfunction
infection
both
(|
ρ
|
>
0.33,
s
0.042).
In
pooled
group,
specifically
associated
higher
abundance
Dialister
Clostridia_UCG-014
,
levels
LPS
neurodegeneration
(|ρ|
0.32,
0.048
all).
performance
Acetonema
Bifidobacterium
[Eubacterium]_coprostanoligenes_group
Collinsella
0.30,
0.049).
Discussion
These
results
support
hypothesis
that
dysbiosis
may
have
distinct
effects
different
mechanisms
action
depending
disease.
Language: Английский
Disorders of gut microbiota and fecal–serum metabolic patterns are associated with pulmonary tuberculosis and pulmonary tuberculosis comorbid type 2 diabetes mellitus
Yunguang Wang,
No information about this author
Xinxin He,
No information about this author
Yixuan Gao
No information about this author
et al.
Microbiology Spectrum,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 14, 2025
ABSTRACT
Pulmonary
tuberculosis
(PTB)
and
diabetes
mellitus
(DM)
are
prevalent
chronic
diseases
with
substantial
implications
for
human
health.
DM
patients
more
susceptible
to
PTB,
which
exacerbates
diabetes-related
complications.
However,
the
complex
molecular
mechanisms
underlying
enhanced
susceptibility
of
PTB
infection
remain
poorly
understood.
In
this
study,
α-
β-diversity
gut
microbiota
was
significantly
reduced
in
PTB–DM
patients.
The
abundances
families
Lachnospiraceae
Ruminococcaceae
Firmicutes
phylum
were
further
diminished
On
other
hand,
untargeted
metabolomics
frozen
serum
stool
samples
indicated
that
phenylalanine,
tyrosine,
tryptophan
biosynthesis,
metabolites
arginine,
proline,
tryptophan,
histidine
consistently
altered
patients,
significant
upregulation
most
metabolites.
Amino
acids
like
serine,
both
remarkably
elevated
correlation
network
analysis
reveals
relationships
between
shared
microbial
biomarkers
metabolic
pathways.
This
research
contributes
exploration
pivotal
diagnostic
accompanied
by
diabetes.
Specifically,
reductions
identified
genera
g-Roseburia
,
g-Ruminococcaceae_UCG.013
g-Ruminococcaceae_NK4A214
g-Lachnospiraceae
_
unclassified
g-Firmicutes
addition
notable
regulation
amino
acids,
glycine,
PTB–DM.
Our
study
expands
comprehension
intricate
connections
linking
microbiota,
fecal
metabolites,
IMPORTANCE
understanding
links
PTB-DM
through
multi-omics
techniques.
It
is
helpful
us
understand
mechanism
increased
diabetic
Language: Английский
Role of Antioxidants in Modulating the Microbiota–Gut–Brain Axis and Their Impact on Neurodegenerative Diseases
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3658 - 3658
Published: April 12, 2025
This
narrative
review
presents
the
role
of
antioxidants
in
regulating
gut
microbiota
and
impact
on
gut–brain
axis,
with
a
particular
focus
neurodegenerative
diseases,
such
as
Alzheimer’s
(AD)
Parkinson’s
disease
(PD).
These
diseases
are
characterised
by
cognitive
decline,
motor
dysfunction,
neuroinflammation,
all
which
significantly
exacerbated
oxidative
stress.
elucidates
contribution
damage
to
progression
explores
potential
mitigate
these
pathological
processes
through
modulation
associated
pathways.
Based
recent
studies
retrieved
from
reputable
databases,
including
PubMed,
Web
Science,
Scopus,
this
article
outlines
mechanisms
influence
health
exert
neuroprotective
effects.
Specifically,
it
discusses
how
antioxidants,
polyphenols,
vitamins,
flavonoids,
contribute
reduction
reactive
oxygen
species
(ROS)
production
thereby
promoting
neuronal
survival
minimising
brain.
In
addition,
modulating
key
molecular
pathways
involved
stress
NF-κB,
Nrf2,
MAPK,
PI3K/AKT
pathways,
regulate
ROS
generation,
inflammatory
cytokine
expression,
antioxidant
responses
essential
for
maintaining
cellular
homeostasis
both
central
nervous
system.
complex
relationship
between
gut-derived
metabolites,
stress,
highlighting
dysbiosis—an
imbalance
microbiota—can
exacerbate
accelerating
AD
PD.
The
also
examines
short-chain
fatty
acids
(SCFAs)
produced
beneficial
bacteria
attenuate
neuroinflammation
damage.
Furthermore,
therapeutic
microbiota-targeted
interventions,
delivery
probiotics
prebiotics,
innovative
strategies
restore
microbial
support
brain
health.
By
synthesising
current
knowledge
interplay
underlying
neurodegeneration,
highlights
promise
antioxidant-based
interventions
mitigating
progression.
It
need
further
research
into
antioxidant-rich
dietary
microbiota-focused
therapies
promising
avenues
prevention
treatment
diseases.
Language: Английский
Could a Mediterranean Diet Modulate Alzheimer’s Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration
Foods,
Journal Year:
2025,
Volume and Issue:
14(9), P. 1559 - 1559
Published: April 29, 2025
Neurodegenerative
disorders
such
as
Alzheimer’s
disease
(AD),
the
most
common
form
of
dementia,
represent
a
growing
global
health
crisis,
yet
current
treatment
strategies
remain
primarily
palliative.
Recent
studies
have
shown
that
neurodegeneration
through
complex
interactions
within
gut–brain
axis
largely
depends
on
gut
microbiota
and
its
metabolites.
This
review
explores
intricate
molecular
mechanisms
linking
dysbiosis
to
cognitive
decline,
emphasizing
impact
microbial
metabolites,
including
short-chain
fatty
acids
(SCFAs),
bile
acids,
tryptophan
neuroinflammation,
blood–brain
barrier
(BBB)
integrity,
amyloid-β
tau
pathology.
The
paper
highlights
major
microbiome
signatures
associated
with
disease,
detailing
their
metabolic
pathways
inflammatory
crosstalk.
Dietary
interventions
promise
in
modulating
composition,
potentially
mitigating
neurodegenerative
processes.
critically
examines
influence
dietary
patterns,
Mediterranean
Western
diets,
microbiota-mediated
neuroprotection.
Bioactive
compounds
like
prebiotics,
omega-3
polyphenols
exhibit
neuroprotective
effects
by
reducing
neuroinflammation.
Furthermore,
it
discusses
emerging
microbiome-based
therapeutic
strategies,
probiotics,
postbiotics,
fecal
transplantation
(FMT),
potential
for
slowing
progression.
Despite
these
advances,
several
knowledge
gaps
remain,
interindividual
variability
responses
need
large-scale,
longitudinal
studies.
study
proposes
an
integrative,
precision
medicine
approach,
incorporating
science
into
paradigms.
Ultimately,
cognizance
at
mechanistic
level
could
unlock
novel
avenues,
offering
non-invasive,
diet-based
strategy
managing
improving
health.
Language: Английский
The Complex Relationship Between Gut Microbiota and Alzheimer’s Disease: A Systematic Review
Xuan-Peng Zhou,
No information about this author
Lei Sun,
No information about this author
Wenhao Liu
No information about this author
et al.
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
unknown, P. 102637 - 102637
Published: Dec. 1, 2024
Alzheimer's
disease
(AD)
is
a
progressive,
degenerative
disorder
of
the
central
nervous
system.
Despite
extensive
research
conducted
on
this
disorder,
its
precise
pathogenesis
remains
unclear.
In
recent
years,
microbiota-gut-brain
axis
has
attracted
considerable
attention
within
field
AD.
The
gut
microbiota
communicates
bidirectionally
with
system
through
gut-brain
axis,
and
alterations
in
structure
function
can
influence
progression
Consequently,
regulating
to
mitigate
AD
emerged
as
novel
therapeutic
approach.
Currently,
numerous
studies
concentrate
intrinsic
relationship
between
paper,
we
summarize
multifaceted
role
present
detailed
strategies
targeting
microbiota,
including
treatment
Traditional
Chinese
Medicine
(TCM),
which
garnered
increasing
years.
Finally,
discuss
potential
for
modulating
alleviate
AD,
current
challenges
area
research,
provide
an
outlook
future
directions
field.
Language: Английский
Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut–Brain Axis and Helicobacter pylori Infection
Neurology International,
Journal Year:
2024,
Volume and Issue:
16(6), P. 1750 - 1778
Published: Dec. 6, 2024
Background:
The
innate
immune
response
aims
to
prevent
pathogens
from
entering
the
organism
and/or
facilitate
pathogen
clearance.
Innate
cells,
such
as
macrophages,
mast
cells
(MCs),
natural
killer
and
neutrophils,
bear
pattern
recognition
receptors
are
thus
able
recognize
common
molecular
patterns,
pathogen-associated
patterns
(PAMPs),
damage-associated
(DAMPs),
later
occurring
in
context
of
neuroinflammation.
An
inflammatory
component
pathology
otherwise
“primary
cerebrovascular
neurodegenerative”
disease
has
recently
been
recognized
targeted
a
means
therapeutic
intervention.
Activated
MCs
multifunctional
effector
generated
hematopoietic
stem
that,
together
with
dendritic
represent
first-line
defense
mechanisms
against
tissue
destruction.
Methods:
This
review
summarize
evidence
MC
implication
pathogenesis
neurodegenerative
diseases,
namely,
Alzheimer’s
disease,
Parkinson’s
amyotrophic
lateral
sclerosis,
Huntington’s
multiple
sclerosis.
Results:
In
view
recent
that
gut–brain
axis
may
be
implicated
diseases
characterization
neuroinflammatory
these
this
also
focuses
on
potential
mediators
bi-directional
communication
possible
role
Helicobacter
pylori,
gastric
known
alter
homeostasis
towards
local
systemic
pro-inflammatory
responses.
Conclusion:
As
pylori
infection
offer
targets
intervention
implications
for
more
clinical
translational
is
needed
elucidate
field.
Language: Английский